Sensex
83,277.15 profit arw 650.39 (0.79%)
Nifty
25,682.75 profit arw 211.65 (0.83%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 16-Feb-2026
Corporate News
16-Feb-2026     19:10

USFDA completes inspection of Enzene's manufacturing unit at Chakan, Pune

Alkem Laboratories announced that the United States Food and Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) on 13 February, 2026 at the manufacturing facility of Enzene Biosciences (Enzene), a subsidiary of the Company in India located at Chakan, Pune.

At the conclusion of the inspection, the USFDA issued a Form 483 with 6 procedural observations. Enzene has achieved Zero observations related to data integrity - a critical validation of Enzene's quality systems and the reliability of regulatory filings.

Enzene is in the process of preparing and submitting its response to the USFDA within the stipulated timeline and has initiated appropriate corrective and preventive actions.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

83,277.15 650.39 (0.79%)

Nifty

25,682.75 211.65 (0.83%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

26,567.13 -465.42(-1.72%)